Post-Approval watch: tracking cancer drug performance in actual patients

NCT ID NCT07132567

Recruiting now Disease control Sponsor: Kyowa Kirin Co., Ltd. Source: ClinicalTrials.gov ↗

Summary

This study monitors how well Poteligeo works and what side effects occur when used in routine medical practice for adults with mycosis fungoides or Sézary syndrome—rare types of skin cancer. Researchers will track 15 Korean patients who have tried at least one other treatment before receiving Poteligeo injections. The goal is to gather real-world safety and effectiveness data after the drug's approval.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chung-Ang University Hospital
TERMINATED

Seoul, South Korea
Ewha Womans University Mokdong Hospital
RECRUITING

Seoul, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Kosin University Gospel Hospital
RECRUITING

Busan, Busan Metropolitan City, 49267, South Korea

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Samsung Medical Center
RECRUITING

Seoul, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Seoul National University Hospital
RECRUITING

Seoul, South Korea
Seoul National University Hospital
RECRUITING

Seoul, South Korea

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

MYCOSIS FUNGOIDES SEZARY SYNDROME